NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 200 filers reported holding NEKTAR THERAPEUTICS in Q2 2017. The put-call ratio across all filers is 0.28 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $709,099 | -72.4% | 1,190,563 | -73.4% | 0.00% | -100.0% |
Q2 2023 | $2,571,615 | +6428937.5% | 4,470,818 | +7848.5% | 0.00% | – |
Q1 2023 | $40 | -97.1% | 56,247 | -90.8% | 0.00% | -100.0% |
Q4 2022 | $1,385 | -99.7% | 612,909 | +286.9% | 0.00% | – |
Q3 2022 | $507,000 | -96.4% | 158,411 | -94.0% | 0.00% | -100.0% |
Q1 2022 | $14,263,000 | -38.0% | 2,646,223 | +55.4% | 0.01% | -41.7% |
Q4 2021 | $23,000,000 | +94.9% | 1,702,403 | +159.1% | 0.01% | +71.4% |
Q3 2021 | $11,799,000 | +19.3% | 656,953 | +14.0% | 0.01% | +16.7% |
Q2 2021 | $9,891,000 | +358.3% | 576,389 | +434.2% | 0.01% | +200.0% |
Q1 2021 | $2,158,000 | -82.4% | 107,903 | -85.0% | 0.00% | -77.8% |
Q4 2020 | $12,254,000 | +561.3% | 720,838 | +545.5% | 0.01% | +350.0% |
Q3 2020 | $1,853,000 | -14.4% | 111,673 | +19.4% | 0.00% | -33.3% |
Q2 2020 | $2,165,000 | -9.5% | 93,492 | -30.2% | 0.00% | -40.0% |
Q1 2020 | $2,391,000 | -83.0% | 133,975 | -79.5% | 0.01% | -72.2% |
Q4 2019 | $14,082,000 | -21.9% | 652,420 | -34.1% | 0.02% | -37.9% |
Q3 2019 | $18,034,000 | -68.0% | 990,098 | +7.2% | 0.03% | -58.0% |
Q3 2018 | $56,278,000 | -24.1% | 923,202 | -39.2% | 0.07% | -28.9% |
Q2 2018 | $74,153,000 | -38.1% | 1,518,593 | +34.8% | 0.10% | -39.4% |
Q1 2018 | $119,737,000 | +5974.9% | 1,126,828 | +3314.6% | 0.16% | +5233.3% |
Q4 2017 | $1,971,000 | -81.7% | 33,000 | -92.8% | 0.00% | -85.0% |
Q1 2017 | $10,783,000 | +110.6% | 459,457 | +10.1% | 0.02% | +81.8% |
Q4 2016 | $5,120,000 | -32.2% | 417,312 | -5.0% | 0.01% | -15.4% |
Q3 2016 | $7,551,000 | +1020.3% | 439,503 | +828.0% | 0.01% | +550.0% |
Q2 2016 | $674,000 | -97.3% | 47,359 | -97.4% | 0.00% | -96.8% |
Q1 2016 | $25,342,000 | +36.7% | 1,843,044 | +67.6% | 0.06% | +61.5% |
Q4 2015 | $18,533,000 | -58.1% | 1,099,867 | -72.7% | 0.04% | -54.7% |
Q3 2015 | $44,224,000 | +794.7% | 4,035,015 | +921.3% | 0.09% | +855.6% |
Q2 2015 | $4,943,000 | -47.0% | 395,100 | -53.4% | 0.01% | -47.1% |
Q1 2015 | $9,333,000 | -15.9% | 848,485 | +18.4% | 0.02% | -29.2% |
Q4 2014 | $11,104,000 | +226.8% | 716,356 | +154.5% | 0.02% | +166.7% |
Q3 2014 | $3,398,000 | -35.4% | 281,511 | -31.4% | 0.01% | -40.0% |
Q2 2014 | $5,259,000 | +169.3% | 410,186 | +154.5% | 0.02% | +150.0% |
Q1 2014 | $1,953,000 | -2.5% | 161,168 | -8.7% | 0.01% | 0.0% |
Q4 2013 | $2,004,000 | -84.7% | 176,583 | -85.9% | 0.01% | -85.7% |
Q3 2013 | $13,087,000 | +21.6% | 1,252,872 | +34.4% | 0.04% | +27.3% |
Q2 2013 | $10,763,000 | – | 931,851 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TIRSCHWELL & LOEWY INC | 588,908 | $7,138,000 | 1.23% |
Granahan Investment Management | 3,693,956 | $44,771,000 | 1.21% |
NEA Management Company, LLC | 1,825,600 | $22,126,000 | 1.09% |
FIC CAPITAL INC | 150,868 | $1,829,000 | 0.75% |
Rhenman & Partners Asset Management AB | 181,797 | $2,203,000 | 0.66% |
SOPHROSYNE CAPITAL LLC | 60,200 | $728,000 | 0.64% |
HARVEY CAPITAL MANAGEMENT INC | 130,400 | $1,580,000 | 0.63% |
Artal Group S.A. | 1,300,000 | $15,756,000 | 0.57% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 564,418 | $6,840,000 | 0.47% |
OppenheimerFunds, Inc. | 24,400,000 | $295,728,000 | 0.35% |